Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Clinical Research of South Florida
mi
from
Coral Gables, FL
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Clinical Research of South Florida
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Avail Clinical Research
mi
from
DeLand, FL
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Suncoast Research Group, LLC
mi
from
Miami, FL
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Suncoast Research Group, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
QPS MRA, dba Miami Research Associates, LLC
mi
from
South Miami, FL
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
QPS MRA, dba Miami Research Associates, LLC
mi
from
South Miami, FL
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Palm Beach Research Center
mi
from
West Palm Beach, FL
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Palm Beach Research Center
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
WR-Mount Vernon Clinical Research
mi
from
Sandy Springs, GA
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
WR-Mount Vernon Clinical Research
mi
from
Sandy Springs, GA
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
East-West Medical Research Institute
mi
from
Honolulu, HI
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
East-West Medical Research Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Midwest Institute for Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Crescent City Clinical Research Center
mi
from
Metairie, LA
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Crescent City Clinical Research Center
mi
from
Metairie, LA
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
St. Louis Clinical Trials, LC
mi
from
St. Louis, MO
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
St. Louis Clinical Trials, LC
mi
from
St. Louis, MO
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
ALAS Science Clinical Research
mi
from
Las Vegas, NV
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
ALAS Science Clinical Research
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Comprehensive Clinical Research
mi
from
Berlin, NJ
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Comprehensive Clinical Research
mi
from
Berlin, NJ
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Clinilabs, Inc.
mi
from
Eatontown, NJ
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Clinilabs, Inc.
mi
from
Eatontown, NJ
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Pharmaceutical Research Associates, Inc.
mi
from
Marlton, NJ
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
TLB Research LLC
mi
from
Trenton, NJ
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
TLB Research LLC
mi
from
Trenton, NJ
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Randolph Medical Associates
mi
from
Asheboro, NC
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Randolph Medical Associates
mi
from
Asheboro, NC
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
High Point Clinical Trials Center
mi
from
High Point, NC
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
High Point Clinical Trials Center
mi
from
High Point, NC
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Lillestol Research LLC
mi
from
Fargo, ND
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Lillestol Research LLC
mi
from
Fargo, ND
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Aventiv Research
mi
from
Columbus, OH
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Aventiv Research
mi
from
Columbus, OH
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Juno Research
mi
from
Houston, TX
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Juno Research
mi
from
Houston, TX
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Texas Center for Drug Development, P.A.
mi
from
Houston, TX
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Juno Research, LLC
mi
from
Katy, TX
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Juno Research, LLC
mi
from
Katy, TX
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Northeast Clinical Research of San Antonio, LLC
mi
from
Schertz, TX
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Northeast Clinical Research of San Antonio, LLC
mi
from
Schertz, TX
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated:  8/16/2016
Aggarwal and Associates Limited
mi
from
Brampton,
A 12-week Study To Evaluate PF-06291874 Once a Day in Adults With T2DM Inadequately Controlled On Metformin
A 12-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Once Daily Pf-06291874 Administration In Adults With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin
Status: Enrolling
Updated: 8/16/2016
Aggarwal and Associates Limited
mi
from
Brampton,
Click here to add this to my saved trials
Intravenous Exenatide (Byetta) During Surgery
Intravenous Exenatide (Byetta) for the Treatment of Perioperative Hyperglycemia: Rollover Phase I/II Trial
Status: Enrolling
Updated:  8/17/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Intravenous Exenatide (Byetta) During Surgery
Intravenous Exenatide (Byetta) for the Treatment of Perioperative Hyperglycemia: Rollover Phase I/II Trial
Status: Enrolling
Updated: 8/17/2016
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Retina-Vitreous Associates Medical Group
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
University of California, Irvine
mi
from
Irvine, CA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Loma Linda University Health Care, Dept. of Ophthalmology
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Southern California Desert Retina Consultants, MC
mi
from
Palm Springs, CA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Southern California Desert Retina Consultants, MC
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
California Retina Consultants
mi
from
Santa Barbara, CA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
California Retina Consultants
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Bay Area Retina Associates
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Eldorado Retina Associates
mi
from
Louisville, CO
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Eldorado Retina Associates
mi
from
Louisville, CO
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Retina Consultants of Southwest Florida
mi
from
Fort Myers, FL
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Retina Consultants of Southwest Florida
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Retina Vitreous Consultants
mi
from
Ft. Lauderdale, FL
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Retina Vitreous Consultants
mi
from
Ft. Lauderdale, FL
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Central Florida Retina Institute
mi
from
Lakeland, FL
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Central Florida Retina Institute
mi
from
Lakeland, FL
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Southeast Retina Center, P.C.
mi
from
Augusta, GA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
University of Illinois at Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Illinois Retina Associates
mi
from
Joliet, IL
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Illinois Retina Associates
mi
from
Joliet, IL
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
John-Kenyon American Eye Institute
mi
from
New Albany, IN
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
John-Kenyon American Eye Institute
mi
from
New Albany, IN
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Medical Associates Clinic, PC
mi
from
Dubuque, IA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Medical Associates Clinic, PC
mi
from
Dubuque, IA
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Paducah Retinal Center
mi
from
Paducah, KY
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Paducah Retinal Center
mi
from
Paducah, KY
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Maine Vitreoretinal Consultants
mi
from
Bangor, ME
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Maine Vitreoretinal Consultants
mi
from
Bangor, ME
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Elman Retina Group, PA
mi
from
Baltimore, MD
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Elman Retina Group, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Wilmer Ophthalmological Institute at Johns Hopkins
mi
from
Baltimore, MD
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Wilmer Ophthalmological Institute at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Retina Consultants of Delmarva, P.A.
mi
from
Salisbury, MD
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Retina Consultants of Delmarva, P.A.
mi
from
Salisbury, MD
Click here to add this to my saved trials
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated:  8/25/2016
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Intravitreal Ranibizumab or Triamcinolone Acetonide as Adjunctive Treatment to Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Status: Enrolling
Updated: 8/25/2016
Ophthalmic Consultants of Boston
mi
from
Boston, MA
Click here to add this to my saved trials